Search

Your search keyword '"Ravaglia, Sabrina"' showing total 332 results

Search Constraints

Start Over You searched for: Author "Ravaglia, Sabrina" Remove constraint Author: "Ravaglia, Sabrina"
332 results on '"Ravaglia, Sabrina"'

Search Results

3. Myo-regressor Deep Informed Neural NetwOrk (Myo-DINO) for fast MR parameters mapping in neuromuscular disorders

4. Safety outcomes and patients’ preferences for home-based intravenous enzyme replacement therapy (ERT) in pompe disease and mucopolysaccharidosis type I (MPS I) disorder: COVID-19 and beyond

6. SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues

13. Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study Group

14. Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy: Advancement and Challenges

18. A Chaperone Enhances Blood α-Glucosidase Activity in Pompe Disease Patients Treated With Enzyme Replacement Therapy

22. Guillain‐Barré syndrome and COVID ‐19: A 1‐year observational multicenter study

23. Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis

28. Guillain-barré syndrome and COVID-19: An observational multicenter study

29. Bioimpedance Phase Angle as a Prognostic Tool in Late-Onset Pompe Disease: A Single-Centre Prospective Study With a 15-year Follow-Up

30. Multicenter, non-interventional, double cohort study to assess the safety of alglucosidase alfa and laronidase in real-world home infusion setting

31. Enzyme replacement therapy improves respiratory outcomes in patients with late-onset type II glycogenosis and high ventilator dependency

33. Polymorphism in exercise genes and respiratory function in late-onset Pompe disease

42. Mapping the human genetic architecture of COVID-19

43. Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions

44. SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues

46. COVID‐19 in patients with myasthenia gravis: Epidemiology and disease course

Catalog

Books, media, physical & digital resources